Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CLPS (CLPS) Cash & Equivalents: 2017-2025

  • CLPS's Cash & Equivalents fell 3.24% to $28.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $28.2 million, marking a year-over-year decrease of 3.24%. This contributed to the annual value of $28.2 million for FY2025, which is 3.24% down from last year.
  • According to the latest figures from Q2 2025, CLPS's Cash & Equivalents is $28.2 million, which was down 3.24% from $29.1 million recorded in Q2 2024.
  • In the past 5 years, CLPS's Cash & Equivalents registered a high of $29.1 million during Q2 2024, and its lowest value of $18.4 million during Q2 2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $28.2 million (2025), whereas its average is $26.5 million.
  • As far as peak fluctuations go, CLPS's Cash & Equivalents spiked by 95.54% in 2021, and later decreased by 25.64% in 2022.
  • Quarterly analysis of 5 years shows CLPS's Cash & Equivalents stood at $24.7 million in 2021, then fell by 25.64% to $18.4 million in 2022, then rose by 20.75% to $22.2 million in 2023, then soared by 31.07% to $29.1 million in 2024, then fell by 3.24% to $28.2 million in 2025.
  • Its Cash & Equivalents was $28.2 million in Q2 2025, compared to $29.1 million in Q2 2024 and $22.2 million in Q2 2023.